Nano Cap New Millennium Growth Fund L P Takes $630,000 Position in 908 Devices Inc. $MASS

Nano Cap New Millennium Growth Fund L P acquired a new stake in shares of 908 Devices Inc. (NASDAQ:MASS) during the 4th quarter, Holdings Channel reports. The fund acquired 120,000 shares of the company’s stock, valued at approximately $630,000.

A number of other large investors also recently added to or reduced their stakes in MASS. First Light Asset Management LLC lifted its holdings in 908 Devices by 135.2% in the 3rd quarter. First Light Asset Management LLC now owns 2,510,496 shares of the company’s stock worth $21,992,000 after purchasing an additional 1,442,883 shares in the last quarter. Marshall Wace LLP lifted its holdings in 908 Devices by 359.4% in the 2nd quarter. Marshall Wace LLP now owns 648,796 shares of the company’s stock worth $4,626,000 after purchasing an additional 507,562 shares in the last quarter. First Eagle Investment Management LLC lifted its holdings in 908 Devices by 125.9% in the 3rd quarter. First Eagle Investment Management LLC now owns 603,962 shares of the company’s stock worth $5,291,000 after purchasing an additional 336,584 shares in the last quarter. Bank of America Corp DE lifted its holdings in 908 Devices by 221.7% in the 2nd quarter. Bank of America Corp DE now owns 363,217 shares of the company’s stock worth $2,590,000 after purchasing an additional 250,311 shares in the last quarter. Finally, HighMark Wealth Management LLC purchased a new position in 908 Devices in the 4th quarter worth approximately $1,265,000. 88.06% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other 908 Devices news, SVP John Kenneweg sold 7,787 shares of the business’s stock in a transaction that occurred on Friday, May 1st. The stock was sold at an average price of $6.83, for a total transaction of $53,185.21. Following the sale, the senior vice president directly owned 76,039 shares of the company’s stock, valued at $519,346.37. The trade was a 9.29% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, SVP Kevin J. Mccallion sold 5,420 shares of the stock in a transaction on Thursday, April 9th. The shares were sold at an average price of $7.03, for a total transaction of $38,102.60. Following the completion of the sale, the senior vice president directly owned 44,925 shares in the company, valued at approximately $315,822.75. This represents a 10.77% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 94,480 shares of company stock valued at $668,032 over the last ninety days. 28.20% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

A number of research firms recently commented on MASS. Wall Street Zen cut 908 Devices from a “buy” rating to a “hold” rating in a report on Saturday, May 9th. Weiss Ratings cut 908 Devices from a “hold (c-)” rating to a “sell (d-)” rating in a report on Monday, May 11th. One equities research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, 908 Devices currently has a consensus rating of “Hold” and a consensus target price of $12.00.

908 Devices Price Performance

Shares of NASDAQ MASS opened at $7.12 on Friday. The business’s 50 day moving average is $6.80 and its two-hundred day moving average is $6.42. 908 Devices Inc. has a 1-year low of $4.47 and a 1-year high of $9.34. The stock has a market capitalization of $269.21 million, a P/E ratio of -7.12 and a beta of 0.57.

908 Devices (NASDAQ:MASS) last issued its quarterly earnings data on Tuesday, March 3rd. The company reported ($0.05) earnings per share for the quarter, topping the consensus estimate of ($0.06) by $0.01. 908 Devices had a negative return on equity of 14.03% and a negative net margin of 62.40%.The company had revenue of $17.38 million for the quarter, compared to analysts’ expectations of $16.19 million. As a group, equities research analysts anticipate that 908 Devices Inc. will post -0.38 earnings per share for the current fiscal year.

908 Devices Company Profile

908 Devices Inc (NASDAQ: MASS) is a developer and manufacturer of portable analytical instruments designed to deliver rapid chemical detection in field and laboratory environments. The company’s core focus lies in miniaturizing high-performance mass spectrometry and ion mobility spectrometry technologies, enabling users to perform on-site analysis that traditionally required benchtop equipment.

Key products in 908 Devices’ portfolio include the MX908, a handheld high-resolution mass spectrometer capable of detecting and identifying a broad range of chemicals and explosives; the M908 portable mass spectrometer for laboratory or mobile units; and the ZipChip capillary electrophoresis system for high-throughput, microfluidic separations.